Notice of Participation of NIAID in Extension of PAR-12-032 "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Etiology, Diagnosis, Pathophysiology, and Treatment (R01)" by an Additional Funding Cycle

Notice Number:

NOT-AI-15-007

Key Dates

Release Date: November 4, 2014

Related Announcements

PAR-12-032

NOT-OD-15-006

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Allergy and Infectious Diseases (NIAID) is participating in the extension of PAR-12-032, entitled "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Etiology, Diagnosis, Pathophysiology, and Treatment (R21)" by an additional funding cycle.

The following sections of PAR-12-032 are updated to reflect the participation of NIAID in this FOA.

Part 1. Overview Information

Components of Participating Organizations

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute on Dental and Craniofacial Research (NIDCR)

National Institute of Neurological Disorders and Stroke (NINDS)

Office of Behavioral and Social Sciences Research (OBSSR)

Office of Research on Women’s Health (ORWH)

National Institute of Allergy and Infectious Diseases (NIAID)

Catalog of Federal Domestic Assistance (CFDA) Number(s): 93.855, 93.856 (NIAID)

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

Timothy Gondré-Lewis, Ph.D.
Allergy, Immunology, and Transplantation
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3566
Email: [email protected]

Eun Chung Park, M.D.
Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3338
Email: [email protected]

Financial/Grants Management Contact(s)

Donna Sullivan
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2979
Email: [email protected]

Please note that this Notice overrides NOT-OD-15-006 originally indicating NIAID withdrawing participation from the FOA for the additional funding cycle.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Timothy Gondré-Lewis, Ph.D.
Allergy, Immunology, and Transplantation
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3566
Email: [email protected]

Eun Chung Park, M.D.
Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3338
Email: [email protected]